Sandip Kanse

Professor Sandip Kanse is a leading academic at the University of Oslo, Department of Medical Biochemistry, specializing in Vascular Pathophysiology. With over three decades of experience, his work bridges protease biology and cardiovascular diseases, focusing on Factor VII Activating Protease (FSAP) in contexts ranging from stroke to liver fibrosis. As head of the Biochemistry section since 2018, he oversees critical research in thrombosis, atherosclerosis, and inflammatory pathways.

• Education: Habilitation (University of Giessen, 2003), PhD (University of London, 1991), BSc Biochemistry (University of London, 1986)

Research Themes center on the dual roles of FSAP in coagulation and inflammation, with implications for ischemic stroke, venous thrombosis, and endothelial dysfunction. His work explores protease-activated receptors, angiogenesis, and complement activation in disease states.

Article Trends reveal a focus on FSAP's enzymatic properties, substrate specificity, and pathophysiological roles across neurovascular, cardiovascular, and oncological domains. Collaborative studies span animal models, clinical trials, and structural bioinformatics.

Training Leadership: Supervises doctoral candidates in experimental haemostasis and protease function, while contributing to international projects on stroke diagnostics and transplanted brain organoids.